Vascepa 1gm price?

What drives the price of 1g Vascepa?

Vascepa (icosapent ethyl) 1g costs $350–$450 for a 120-capsule bottle at most retail pharmacies without insurance or discounts. The list price set by Amarin is roughly $460 per month’s supply. [1]

Why is Vascepa so expensive compared to fish oil?

Vascepa contains purified icosapent ethyl, a single EPA-only molecule that cleared cardiovascular-outcome trials, while generic fish-oil supplements contain mixtures of EPA and DHA plus contaminants. Those trial results let Amarin justify a premium price. [2]

How long does the 1g dose usually run out?

Two 1g capsules twice daily give a monthly supply of 120 capsules. Patients therefore buy one bottle every month unless they use a 90-day fill option.

When does Vascepa’s patent expire?

Vascepa’s key patents expire in 2030. Biosimilars and generics cannot launch until then unless earlier challenges succeed. Amarin maintains an active litigation program against would-be entrants. [3]

Who produces Vascepa?

Amarin Pharma markets Vascepa exclusively in the U.S. and keeps the manufacture of icosapent ethyl under its own control.

What alternatives exist if price remains a barrier?

Generic icosapent ethyl is not yet available. Patients sometimes turn to over-the-counter fish-oil capsules or Lovaza (omega-3-acid ethyl esters), but clinical data show Lovaza contains DHA and is not a direct substitute. [4]

Can patients cut costs legally?

Amarin offers a savings card that brings copays down to $9 for insured patients. Uninsured patients can use GoodRx coupons to obtain the 120-count bottle for $340–$380 at several chains. [5]

When is Vascepa patent expiry scheduled?

See above: core intellectual-property protection runs through 2030.